Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
GlaxoSmithKline.
Real, source-linked trial activity for GlaxoSmithKline: 14 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 20, 2026. Source-linked, daily-refreshed.
PHASE3 10PHASE1 3N/A 1
Newest GlaxoSmithKline trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 3d ago | Individual Patient Expanded Access for Velzatinib (GSK6042981) in Pati | N/A | AVAILABLE | ↗ |
| 16d ago | A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Y | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 17d ago | A Study of Risvutatug Rezetecan in Participants With Metastatic Castra | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 26d ago | A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 27d ago | A Study to Investigate the Efficacy and Safety of GSK5784283 Compared | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 27d ago | A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 27d ago | A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 30d ago | A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorek | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 30d ago | A Study to Investigate the Efficacy and Safety of GSK5784283 Compared | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 30d ago | A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorek | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 46d ago | A Sub Study to Investigate the Safety and Tolerability of Aletekitug i | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 46d ago | A Study to Investigate the Safety and Tolerability of Multiple Study I | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 48d ago | A Study on the Immune Response and Safety of an Investigational Combin | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 48d ago | A Study of the Duration of Dostarlimab in Untreated Mismatch Repair De | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for GlaxoSmithKline (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.